These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23333207)

  • 1. Synthesis and biological evaluation of 2-(arylethynyl)quinoline derivatives as mGluR5 antagonists for the treatment of neuropathic pain.
    Son MH; Kim JY; Lim EJ; Baek DJ; Choi K; Lee JK; Pae AN; Min SJ; Cho YS
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1472-6. PubMed ID: 23333207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of 2-substituted quinoline 6-carboxamides as potential mGluR1 antagonists for the treatment of neuropathic pain.
    Kim Y; Son J; Kim J; Baek DJ; Lee YS; Lim EJ; Lee JK; Pae AN; Min SJ; Cho YS
    Chem Pharm Bull (Tokyo); 2014; 62(6):508-18. PubMed ID: 24881656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of picolinamides and thiazole-2-carboxamides as mGluR5 (metabotropic glutamate receptor 5) antagonists.
    Vu HN; Kim JY; Hassan AH; Choi K; Park JH; Park KD; Lee JK; Pae AN; Choo H; Min SJ; Cho YS
    Bioorg Med Chem Lett; 2016 Jan; 26(1):140-4. PubMed ID: 26598462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive and negative modulation of group I metabotropic glutamate receptors.
    Vanejevs M; Jatzke C; Renner S; Müller S; Hechenberger M; Bauer T; Klochkova A; Pyatkin I; Kazyulkin D; Aksenova E; Shulepin S; Timonina O; Haasis A; Gutcaits A; Parsons CG; Kauss V; Weil T
    J Med Chem; 2008 Feb; 51(3):634-47. PubMed ID: 18173231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent mGluR5 antagonists: pyridyl and thiazolyl-ethynyl-3,5-disubstituted-phenyl series.
    Alagille D; DaCosta H; Chen Y; Hemstapat K; Rodriguez A; Baldwin RM; Conn PJ; Tamagnan GD
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3243-7. PubMed ID: 21546249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, structure-activity relationship, and receptor pharmacology of a new series of quinoline derivatives acting as selective, noncompetitive mGlu1 antagonists.
    Mabire D; Coupa S; Adelinet C; Poncelet A; Simonnet Y; Venet M; Wouters R; Lesage AS; Van Beijsterveldt L; Bischoff F
    J Med Chem; 2005 Mar; 48(6):2134-53. PubMed ID: 15771457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-Aryl-3-arylsulfonyl-quinolines as negative allosteric modulators of metabotropic GluR5 receptors: From HTS hit to development candidate.
    Galambos J; Domány G; Nógrádi K; Wágner G; Keserű GM; Bobok A; Kolok S; Mikó-Bakk ML; Vastag M; Sághy K; Kóti J; Szakács Z; Béni Z; Gál K; Szombathelyi Z; Greiner I
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1249-52. PubMed ID: 26774652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of new 2-chloro-3-((4-phenyl-1H-1,2,3-triazol-1-yl)methyl)quinoline derivatives via click chemistry approach.
    Kategaonkar AH; Shinde PV; Kategaonkar AH; Pasale SK; Shingate BB; Shingare MS
    Eur J Med Chem; 2010 Jul; 45(7):3142-6. PubMed ID: 20435389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of quinoline amide derivatives as novel VEGFR-2 inhibitors.
    Yang Y; Shi L; Zhou Y; Li HQ; Zhu ZW; Zhu HL
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6653-6. PubMed ID: 20943391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of antibacterial activity of 7-alkyloxy-4,5-dihydro-imidazo[1,2-a]quinoline derivatives.
    Sun XY; Wu R; Wen X; Guo L; Zhou CP; Li J; Quan ZS; Bao J
    Eur J Med Chem; 2013 Feb; 60():451-5. PubMed ID: 23321259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationship of 4-(2-aryl-cyclopropylamino)-quinoline-3-carbonitriles as EGFR tyrosine kinase inhibitors.
    Pannala M; Kher S; Wilson N; Gaudette J; Sircar I; Zhang SH; Bakhirev A; Yang G; Yuen P; Gorcsan F; Sakurai N; Barbosa M; Cheng JF
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5978-82. PubMed ID: 17827009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anticancer evaluation of certain 4-anilinofuro[2,3-b]quinoline and 4-anilinofuro[3,2-c]quinoline derivatives.
    Chen YL; Chen IL; Wang TC; Han CH; Tzeng CC
    Eur J Med Chem; 2005 Sep; 40(9):928-34. PubMed ID: 15913847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors.
    Zarghi A; Ghodsi R; Azizi E; Daraie B; Hedayati M; Dadrass OG
    Bioorg Med Chem; 2009 Jul; 17(14):5312-7. PubMed ID: 19560931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-C bond formation at C-2 of a quinoline ring: synthesis of 2-(1H-indol-3-yl)quinoline-3-carbonitrile derivatives as a new class of PDE4 inhibitors.
    Kumar KS; Kiran Kumar S; Yogi Sreenivas B; Gorja DR; Kapavarapu R; Rambabu D; Rama Krishna G; Reddy CM; Basaveswara Rao MV; Parsa KV; Pal M
    Bioorg Med Chem; 2012 Apr; 20(7):2199-207. PubMed ID: 22386978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 4-amino-3-arylsulfoquinolines, a novel non-acetylenic chemotype of metabotropic glutamate 5 (mGlu
    Galambos J; Bielik A; Wágner G; Domány G; Kóti J; Béni Z; Szigetvári Á; Sánta Z; Orgován Z; Bobok A; Kiss B; Mikó-Bakk ML; Vastag M; Sághy K; Krasavin M; Gál K; Greiner I; Szombathelyi Z; Keserű GM
    Eur J Med Chem; 2017 Jun; 133():240-254. PubMed ID: 28390229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of morphine antiallodynic efficacy by ACPT-III, a group III metabotropic glutamate receptor agonist, in rat spinal nerve ligation-induced neuropathic pain.
    Lee HG; Park SK; Yoon MH
    Pharmacol Biochem Behav; 2010 Jul; 96(1):108-13. PubMed ID: 20434481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of some quinoline-2(1H)-one and 1, 2, 4 - triazolo [ 4 , 3 -a ] quinoline derivatives as potent anticonvulsants.
    Guan LP; Jin QH; Tian GR; Chai KY; Quan ZS
    J Pharm Pharm Sci; 2007; 10(3):254-62. PubMed ID: 17727789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro studies of MR imaging probes for metabotropic glutamate subtype-5 receptor targeting.
    Gottschalk S; Engelmann J; Rolla GA; Botta M; Parker D; Mishra A
    Org Biomol Chem; 2013 Sep; 11(36):6131-41. PubMed ID: 23925571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties.
    Gomtsyan A; Bayburt EK; Schmidt RG; Zheng GZ; Perner RJ; Didomenico S; Koenig JR; Turner S; Jinkerson T; Drizin I; Hannick SM; Macri BS; McDonald HA; Honore P; Wismer CT; Marsh KC; Wetter J; Stewart KD; Oie T; Jarvis MF; Surowy CS; Faltynek CR; Lee CH
    J Med Chem; 2005 Feb; 48(3):744-52. PubMed ID: 15689158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinoline tricyclic derivatives. Design, synthesis and evaluation of the antiviral activity of three new classes of RNA-dependent RNA polymerase inhibitors.
    Carta A; Briguglio I; Piras S; Corona P; Boatto G; Nieddu M; Giunchedi P; Marongiu ME; Giliberti G; Iuliano F; Blois S; Ibba C; Busonera B; La Colla P
    Bioorg Med Chem; 2011 Dec; 19(23):7070-84. PubMed ID: 22047799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.